Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-006417
Filing Date
2022-02-15
Accepted
2022-02-15 16:47:15
Documents
1
Period of Report
2022-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5919
  Complete submission text file 0000899243-22-006417.txt   7494
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Issuer) CIK: 0001789972 (see all company filings)

EIN.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CULLINAN MANAGEMENT, INC. ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address
Zawel Leigh (Reporting) CIK: 0001837456 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 22639833